ALAlphabet Inc.
Institutional investor · Portfolio as of Q4 2021
Top Holdings58 positions
UIPATH INC CLASS A | 14.1M | $606.8M | 14.7% | $67.93 | -36.51% | 3 qtrssince 2021-Q2 | Decreased 0 |
VERVE THERAPEUTICS INC | 11M | $404.6M | 9.8% | — | — | 3 qtrssince 2021-Q2 | Unchanged 0 |
DEXCOM INC | 704,011 | $378M | 9.1% | $52.30 | +156.65% | 10 qtrssince 2019-Q3 | Decreased 0 |
IONQ INC | 21.9M | $365.8M | 8.8% | $16.70 | 0.00% | 1 qtr | New 96 |
TOAST INC | 9.5M | $329.6M | 8.0% | $34.71 | 0.00% | 1 qtr | New 96 |
EQRX Inc | 47.6M | $324.3M | 7.8% | — | — | 1 qtr | New 96 |
LYFT INCA | 6.1M | $262.3M | 6.3% | $40.84 | +4.63% | 10 qtrssince 2019-Q3 | Unchanged 0 |
PLANET LABS PBC | 31.9M | $196.4M | 4.7% | $6.15 | 0.00% | 1 qtr | New 85 |
OSCAR HEALTH INC CLASS A | 24M | $188.7M | 4.6% | $26.88 | -70.80% | 4 qtrssince 2021-Q1 | Unchanged 0 |
Benson Hill Inc | 14.8M | $107.5M | 2.6% | — | — | 2 qtrssince 2021-Q3 | Unchanged 0 |
FRESHWORKS INCCL A | 4M | $106M | 2.6% | $26.26 | 0.00% | 1 qtr | New 78 |
ARCUS BIOSCIENCES INC | 2.6M | $103.7M | 2.5% | $9.10 | +344.73% | 10 qtrssince 2019-Q3 | Decreased 0 |
ROBINHOOD MKTS INC | 4.9M | $87.5M | 2.1% | $42.08 | -57.79% | 2 qtrssince 2021-Q3 | Decreased 0 |
Desktop Metal Inc | 11M | $54.7M | 1.3% | — | — | 5 qtrssince 2020-Q4 | Unchanged 0 |
RELAY THERAPEUTICS INC | 1.6M | $48M | 1.2% | $41.74 | -26.43% | 6 qtrssince 2020-Q3 | Decreased 0 |
LYELL IMMUNOPHARMA INC | 5.9M | $45.4M | 1.1% | $324.80 | -52.34% | 3 qtrssince 2021-Q2 | Unchanged 0 |
23ANDME HOLDING CO | 6.7M | $44.9M | 1.1% | — | — | 1 qtr | New 67 |
SANA BIOTECHNOLOGY INC | 2.8M | $43.5M | 1.1% | $33.47 | -53.75% | 4 qtrssince 2021-Q1 | Unchanged 0 |
INVIVYD INC | 5.7M | $41.2M | 1.0% | $42.24 | -82.81% | 2 qtrssince 2021-Q3 | Unchanged 0 |
Science 37 Holdings Inc | 3.2M | $40.4M | 1.0% | — | — | 1 qtr | New 57 |
Alphabet Inc. manages $4.1B across 58 positions as of Q4 2021. Top holdings: PATH (14.7%), VERV (9.8%), DXCM (9.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added IONQ, TOST, EQRX and 12 more; trimmed 10, led by PATH (−3.5M shares). Top move: IONQ (NEW, conviction 96). Portfolio: $4.1B across 58 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR